BioCryst (BCRX) Short-Term Debt to Capital
The BioCryst (BCRX) price chart reflects a debt-to-equity ratio of 0.00. The business relies on the supply of orphan drugs through a network of specialty pharmacies, ensuring high logistics profitability. Despite the current dependence on a single edema medication, management under John Stonehouse is expanding the development pipeline and distribution geography to achieve profitability.
Metric breakdowns and analytics for biocryst.com (BCRX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:BioCryst Pharmaceuticals Inc, BCRX
Operational flexibility is critical for the biotech sector, where BioCryst (BCRX) faces risks associated with the slow commercialization of drugs. This indicator compares liabilities maturing within one year against equity, allowing for an assessment of reliance on external financing during liquidity shortages. By analyzing the short-term debt-to-equity chart, an investor can identify solvency threats amid capital-intensive development.
Competing companies
Argenx (ARGX) - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital BioNTech Pharma (BNTX)|Short-Term Debt to Capital ABVX (Abivax Pharma)|admabiologics.com - Short-Term Debt to Capital|Short-Term Debt to Equity Protagonist (PTGX)|IMVT: Ratio of Short-Term Indebtedness to Capital|KNSA (Kiniksa Pharmaceuticals Ltd) - Short-Term Debt to Equity|Grifols Biemat (GRFS) - Short-Term Debt to Equity Ratio|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com (CLDX)|Aurinia Pharmaceuticals Inc. (AUPH) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Vera Therapeutics Inc (VERA)|Short-Term Debt to Capital DNTH|Pharvaris Pharma - Short-Term Debt to Capital Coefficient|ABCL: Short-Term Debt to Equity|TRML: Short-Term Debt to Equity Ratio|PGEN (Precigen) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Pharming Group NV|NKTR (Nektar) - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital UPB|Short-Term Debt to Equity Zenas Biopharma Inc ZBIO|Short-Term Debt to Capital Ratio immunome.com (IMNM)|GOSS: Short-Term Debt to Capital|Current Liabilities to Capital KalVista Pharma KALV|SEPN - Short-Term Debt to Capital|PVLA - Short-Term Debt to Equity|Savara Inc. - Short-Term Debt to Capital|RIGL (rigel.com) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity ANAB (AnaptysBio)|Current Liabilities to Capital Astria Therapeutics Inc|Short-Term Debt to Capital ENGN (enGene Bio)|Short-Term Debt to Equity Ratio RAPT (rapt.com)|Short-Term Debt to Equity Aerovate Therapeutics|ACRS - Ratio of Short-Term Indebtedness to Capital|KYTX (Kyverna Therapeutics, Inc.) - Short-Term Debt to Equity Ratio|TLSA: Current Liabilities to Capital|Cabaletta Bio, Inc - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Ventyx Biosciences, Inc|Theratechnologies Inc. (THTX) - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio avalotx.com|Short-Term Debt to Capital Eledon Pharmaceuticals, Inc. (ELDN)|Short-Term Debt to Equity Agenus, Inc. (AGEN)|Climb Bio, Inc. - Short-Term Debt to Capital|zurabio.com - Short-Term Debt to Equity Ratio|Short-Term Debt to Equity aTyr Pharma, Inc. (ATYR)|Adagene (ADAG) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio ikenaoncology.com|STTK (Shattuck Labs) - Short-Term Debt to Capital Ratio|Short-Term Debt to Equity Equillium Inc EQ|Current Liabilities to Equity Connect Pharma|Immunic, Inc. (IMUX) - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital atarabio.com (ATRA)|Short-Term Debt to Capital IFRX (InflaRx)|X4 Pharmaceuticals Inc. - Short-Term Debt to Capital|Short-Term Debt to Equity Adicet (ACET)|CELU: Ratio of Short-Term Indebtedness to Capital|INMB (INmune Bio, Inc.) - Short-Term Debt to Equity|barinthusbio.com (BRNS) - Short-Term Debt to Equity Ratio|KZR (Kezar Life Sciences, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital SAB Biotherapeutics Inc. (SABS)|Akari Therapeutics plc (AKTX) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital enlivex.com (ENLV)|Short-Term Debt to Capital QTTB|geovax.com - Short-Term Debt to Capital Coefficient|EDSA: Short-Term Debt to Equity|IBIO: Short-Term Debt to Equity Ratio|CARM (carismatx.com) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio XTL Bio|BOLT (Bolt Biotherapeutics Inc.) - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital HCWB|Short-Term Debt to Equity Aptevo Therapeutics APVO|Short-Term Debt to Capital Ratio aimimmuno.com (AIM)|ADTX: Short-Term Debt to Capital|Current Liabilities to Capital GRI Bio Corporation GRI|XRTX - Short-Term Debt to Capital|HIND - Short-Term Debt to Equity|Revelation Biosciences, Inc. - Short-Term Debt to Capital|INDP (Indaptus Therapeutics Inc) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity SCNI (Scinai)|Current Liabilities to Capital CalciMedica Corp|Short-Term Debt to Capital AFMD (Affimed)|Short-Term Debt to Equity Ratio ALLK (allakos.com)|Short-Term Debt to Equity HOOKIPA Pharma|IGMS - Ratio of Short-Term Indebtedness to Capital|ITOS (iTeos) - Short-Term Debt to Equity Ratio|OCEA: Current Liabilities to Capital|TC Biopharm - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient thirdharmonicbio.com